SOUTH JORDAN, Utah, Oct. 12, 2017 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the quarter ended September 30, 2017, after the close of the stock market on Wednesday, October 25, 2017.
Merit will hold its investor conference call (conference ID 96826880) on the same day (Wednesday, October 25, 2017) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656. A live webcast will also be available for the conference call at merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 4,700 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.
Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



